| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 2,3250% | ₹105 0% | 700 | ₹6 93.54% | 12,40077.77% |
| - | - | 720 | - | - |
| 1,5500% | ₹79.35 0% | 730 | - | - |
| - | - | 740 | ₹12 77.77% | 41,8502600% |
| 3,875400% | ₹63 -23.95% | 750 | ₹13.45 55.49% | 35,65031.42% |
| 4,6500% | ₹55.75 0% | 760 | - | - |
| - | - | 770 | ₹14 0% | 00% |
| 7750% | ₹50 0% | 780 | ₹17 0% | 6,2000% |
| - | - | 790 | ₹25.7 25.67% | 22,475314.28% |
| 1,68,175146.59% | ₹27 -31.03% | 800 | ₹31 29.97% | 91,45037.20% |
| 20,92580% | ₹22.9 -41.8% | 810 | ₹33.85 22.86% | 47,275-1.61% |
| 1,48,800772.72% | ₹19.25 -33.62% | 820 | ₹37.1 13.28% | 13,95063.63% |
| 84,475890.90% | ₹14.8 -42.63% | 830 | ₹35.25 0% | 18,6000% |
| 46,50071.42% | ₹11.2 -44% | 840 | ₹50.7 25.18% | 7,75042.85% |
| 23,250233.33% | ₹8.65 -49.11% | 850 | ₹58 28.88% | 9,300100% |
| - | - | 860 | ₹70.8 86.31% | 1,5500% |
| - | - | 870 | ₹77.85 31.94% | 7750% |
| 68,2001660% | ₹4.6 -43.9% | 880 | ₹82.5 19.47% | 8,5250% |
| 1,54,22519.87% | ₹3 -50% | 900 | ₹105 19.31% | 44,95018.36% |
| 2,3250% | ₹15 0% | 920 | - | - |
| - | - | 930 | - | - |
| 3,1000% | ₹10.9 0% | 940 | ₹120 0% | 3,1000% |
| 6,2000% | ₹3.4 1.49% | 950 | ₹149 16.4% | 9,300140% |
| - | - | 960 | ₹137 0% | 00% |
| 1,5500% | ₹1 0% | 970 | - | - |
| 7750% | ₹9 0% | 980 | ₹110 0% | 2,3250% |
| 3,1000% | ₹7.95 0% | 990 | - | - |
| 19,3754.16% | ₹1.1 0% | 1,000 | ₹193 8.61% | 24,8003.22% |
| - | - | 1,040 | ₹190 0% | 2,3250% |
| - | - | 1,060 | ₹235 0% | 3,8750% |
| 4,6500% | ₹7.9 0% | 1,080 | ₹249.75 0% | 00% |
| - | - | 1,100 | ₹234.5 0% | 00% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
